Skip to main content
Log in

A novel compound heterozygous EPM2A variant in a Chinese family with Lafora disease

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Data availability

The data used and analyzed during the current study are available from the corresponding author on request.

References

  1. Liang T, Wu J, Chen H, Qian J, Xu Z (2022) Novel mutation of EPM2A causes progressive myoclonic epilepsy: a case report. Neurol Sci 43(5):3467–3471

    Article  PubMed  Google Scholar 

  2. Nitschke F, Ahonen SJ, Nitschke S, Mitra S, Minassian BA (2018) Lafora disease—from pathogenesis to treatment strategies. Nat Rev Neurol 14(10):606–617

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Zutt R, Drost G, Vos YJ et al (2016) Unusual course of Lafora disease. Epilepsia open 1(3–4):136–139

    Article  PubMed  PubMed Central  Google Scholar 

  4. Tee SK, Ong TL, Aris A et al (2019) Lafora disease in a Malaysian with a rare mutation in the EPM2A gene. Seizure 67:78–81

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the family for their participation in this study.

Funding

This work was supported by the Project from Zhejiang Provincial Medical and Health Science and Technology Program (2021433847), China.

Author information

Authors and Affiliations

Authors

Contributions

YZ and CJ designed this study. YZ, CG, CJ, and KW were responsible for diagnosis and clinical evaluation. ZY performed pathological analysis. YZ and CJ performed a genetic analysis. YZ analyzed EEG data. YZ and CJ wrote the manuscript. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Caihong Ji.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval and consent to participate

Informed consent was obtained from the patients to publish this case, and approval for this study was provided by the ethics committee of the First Affiliated Hospital of Zhejiang University, School of Medicine.

Consent for publication

The patients signed informed consent regarding publishing their data. Copies of the written consent are available for review by the editor of this journal.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, Y., Guan, C., Yin, Z. et al. A novel compound heterozygous EPM2A variant in a Chinese family with Lafora disease. Acta Neurol Belg (2024). https://doi.org/10.1007/s13760-024-02500-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13760-024-02500-5

Navigation